MPLT

MapLight Therapeutics

MPLT

Market cap $932M

20.55 USD

+0.61

3.06%

At close Updated Dec 19, 4:00 PM EST

Pre-market

After hours

20.32

-0.23

1.12%

1 day

3.06%

5 days

0.2%

1 month

40.75%

3 months

12.05%

6 months

12.05%

Year to date

12.05%

1 year

12.05%

5 years

12.05%

10 years

12.05%

About: MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.

Healthcare Biotechnology

–

Funds holding %

of 7,525 funds

Explore Fund Trends

Analysts bullish %

of 4 analysts

See Analyst Outlook

–

Positive news %

of articles

Check Journalist POV